Evaluating the effectiveness of Danning Tablets for digestive symptoms
Official title: A Prospective Multicentre Real-world Assessment of the Efficacy of Danning Tablets in Alleviating Digestive Symptoms
Run by Shanghai Hutchison Pharmaceuticals Limited · NCT06755671 · Data updated 2026-11-12
This study is testing if Danning Tablets can help people aged 18 to 75 feel better from digestive issues like indigestion and bloating while they are already using the medication.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 75 Years |
| Sex | All |
| Enrollment | 4500 (estimated) |
| Sponsor | Shanghai Hutchison Pharmaceuticals Limited Industry-sponsored |
| Locations | 1 site (Hangzhou, Zhejiang) |
| Status | Recruiting |
| Started | April 30, 2025 |
| Main results expected | June 30, 2027 |
| Study ends | June 30, 2027 |
| Registry record updated | May 14, 2025 |
| Trial ID | NCT06755671 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 to 75 who are currently taking Danning Tablets for digestive issues.
✕Probably not a fit
Patients with severe systemic conditions or a history of certain surgeries or mental illness may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to assess the efficacy of Danning Tablets in alleviating digestive symptoms such as indigestion, bloating, and acid reflux in patients already using the medication. Participants aged 18 to 75 will complete questionnaires at two and four weeks into their treatment to evaluate symptom relief and identify factors influencing effectiveness. The study focuses on real-world data to provide insights into the practical benefits of Danning Tablets for managing dyspepsia.
Why it matters
Potential benefit: If successful, this study could provide evidence supporting the use of Danning Tablets as an effective treatment for digestive symptoms.
How similar studies have gone: While this approach is observational, similar studies evaluating real-world effectiveness of treatments have shown promising results.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients between 18 and 75 years old * Patients with at least one of the following symptoms: upper abdominal pain, bloating, loss of appetite, acid reflux or constipation * Patients already taking Danning Tablets as part of their regular medicine treatment for dyspepsia * Patients agree to sign the informed consent form Exclusion Criteria: * Past history or comorbidity of malignant tumor * Comorbidity of severe systemic condition including cardiovascular, cerebrovascular, renal and hematopoietic system diseases * Past history of abdominal surgery (post pancreatic surgery, post subtotal gastrectomy; incomplete intestinal obstruction) or mental illness, mobility difficulty (e.g. long-term bed ridden) * Comorbidity of any unstable chronic or acute disease,which may impact the evaluation of treatment efficacy as determined by the research physician * Pregnancy or breastfeeding * Participation in other clinical trials within the past 3 months * Other circumstances determined as ineligible by the research physician
Where it's running
-
The Second Affiliated Hospital Zhejiang University School of Medicine
Hangzhou, Zhejiang, China Recruiting
Study contacts
- Principal investigator: Jianting CAI, Doctor of Medicine — Second Affiliated Hospital, Zhejiang University, School of Medicine
- Study coordinator: Yichen GAO, Master of Pharmacy
- Email: gaoyichen@shpl.com.cn
- Phone: +86 13818076897
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Gut health follow-along with Peachbiotic in adults
This single-arm study tests whether Peachbiotic taken daily for 12 weeks helps adults with gut symptoms feel better.
-
Microbiome transplant to treat constipation and bloating in systemic sclerosis
This Phase 2 trial tests whether a frozen or lyophilized microbiome transplant (PRIM‑DJ2727) can help people with systemic sclerosis who have constipation and/or significant bloating.
-
Cognitive Behavioral Therapy for Food Intake Issues in Dyspepsia
This study is testing whether a special kind of therapy delivered online can help adults with functional dyspepsia and food intake issues feel better and improve their eating habits.
-
Low-FODMAP Diet vs Standard Dietary Advice for Functional Dyspepsia
This study tests whether a low-FODMAP diet helps adults with functional dyspepsia compared with standard dietary advice.
-
Prebiotic and Probiotic Combo for Constipation Symptoms
This study tests whether adding 1-kestose to a probiotic (BBH112) helps adults with constipation-related symptoms see more relief and better quality of life.
-
Constipation Prevention Checklist in hip surgery patients
A simple checklist is used to see if hip surgery patients can stay regular by staying hydrated, eating well, moving early, and using abdominal massage.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.